Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 2:54 pm Purchase | 13G | INOZYME PHARMA INC INZY | Rock Springs Capital Management LP | 3,086,027 7.64% | 633,390 (+25.82%) | View |
| 2023-02-14 08:38 am Unchanged | 13G | INOZYME PHARMA INC INZY | Deep Track Capital LP | 3,250,000 8.05% | 0 (Unchanged) | View |
| 2023-02-13 12:09 pm Purchase | 13G | INOZYME PHARMA INC INZY | CHI Advisors LLC | 2,204,876 5.46% | 2,204,876 (New Position) | View |
| 2023-02-10 10:03 am Sale | 13G | INOZYME PHARMA INC INZY | Flynn James E | 0 0% | -2,344,786 (Position Closed) | View |
| 2023-02-09 11:43 am Purchase | 13G | INOZYME PHARMA INC INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,100,138 7.67% | 1,501,110 (+93.88%) | View |
| 2022-04-29 4:05 pm Purchase | 13G | INOZYME PHARMA INC INZY | Venrock Healthcare Capital Partners II L.P. | 4,065,000 9.8% | 4,065,000 (New Position) | View |
| 2022-04-28 4:58 pm Purchase | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 2,661,154 6.6% | 1,070,000 (+67.25%) | View |
| 2022-04-28 4:50 pm Purchase | 13D | INOZYME PHARMA INC INZY | Longitude Capital Partners III LLC | 4,174,379 10.4% | 1,355,000 (+48.06%) | View |
| 2022-04-25 3:05 pm Purchase | 13G | INOZYME PHARMA INC INZY | Rock Springs Capital Management LP | 2,452,637 6.12% | 2,452,637 (New Position) | View |
| 2022-04-18 4:15 pm Purchase | 13G | INOZYME PHARMA INC INZY | Deep Track Capital LP | 3,250,000 8.11% | 3,250,000 (New Position) | View |
| 2022-02-14 09:26 am Unchanged | 13G | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I L.P. | 1,591,154 6.7% | 0 (Unchanged) | View |
| 2022-02-11 4:37 pm Purchase | 13G | INOZYME PHARMA INC INZY | Flynn James E | 2,344,786 9.91% | 1,194,487 (+103.84%) | View |
| 2022-02-10 09:22 am Purchase | 13G | INOZYME PHARMA INC INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,599,028 6.76% | 310,356 (+24.08%) | View |
| 2022-02-07 1:58 pm Unchanged | 13G | INOZYME PHARMA INC INZY | New Enterprise Associates 15 L.P. | 2,437,689 10.3% | 0 (Unchanged) | View |
| 2021-11-15 4:35 pm Sale | 13G | INOZYME PHARMA INC INZY | RA CAPITAL MANAGEMENT L.P. | 0 0% | -2,003,653 (Position Closed) | View |
| 2021-07-30 4:31 pm Sale | 13D | INOZYME PHARMA INC INZY | Novo Holdings A/S | 1,167,706 4.97% | -801,673 (-40.71%) | View |
| 2021-05-10 4:05 pm Purchase | 13G | INOZYME PHARMA INC INZY | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,288,672 5.49% | 1,288,672 (New Position) | View |
| 2021-03-30 4:55 pm Sale | 13D | INOZYME PHARMA INC INZY | Novo Holdings A/S | 1,969,379 8.4% | -225,000 (-10.25%) | View |
| 2021-03-04 06:20 am Purchase | 13D | INOZYME PHARMA INC INZY | Sofinnova Venture Partners X L.P. | 2,028,308 8.7% | 2,028,308 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | INOZYME PHARMA INC INZY | RA CAPITAL MANAGEMENT L.P. | 2,003,653 8.6% | 2,003,653 (New Position) | View |